Trials / Completed
CompletedNCT05878899
Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 77 (actual)
- Sponsor
- University Hospital, Geneva · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In previous attemps to answer the question of risk-benefit of postpartum thromboprophylaxis, researchers were faced with low recruitement rates. The goal of this pilot feasibility randomized controlled trial of postpartum pharmacological thromboprophylaxis is to examine the feasibility (recruitement rate) and participation rate at the Geneva University Hospitals
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Enoxaparin | Prophylactic dose of enoxaparin once daily for 10 days after delivery. |
Timeline
- Start date
- 2022-05-03
- Primary completion
- 2023-03-13
- Completion
- 2023-03-13
- First posted
- 2023-05-26
- Last updated
- 2023-05-26
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05878899. Inclusion in this directory is not an endorsement.